Archives
-
Multiplex PBMC Flow Cytometry for Immunomodulator Screening
2026-09-30
Brox and Hackstein developed a multiplex flow cytometry assay using human PBMCs to measure T-cell proliferation and activation together with B-cell costimulatory responses. Its combination of physiologically relevant primary cells, multiparametric readouts, and Z-factor-based validation provides a practical framework for distinguishing diverse immunomodulatory effects in compound screens.
-
PBS (Phosphate-Buffered Saline) Lab Guide
2026-09-30
PBS (Phosphate-Buffered Saline), SKU K2818, provides a sterile, isotonic solution for cell washing, reagent dilution, and routine in vitro handling where near-physiological pH and osmolarity are needed. It is a research reagent only and should not be used as a growth medium or for diagnostic, clinical, medical, or in vivo applications.
-
Pulchinenoside B4 Targets CD1d–NLRP3 in Colitis
2026-09-29
The 2025 reference study identifies CD1d-dependent NLRP3 inflammasome activation in macrophages as a mechanistic target of Pulchinenoside B4 in DSS-induced colitis. By combining genetic models, cell-type analyses, and target-engagement assays, it links PB4 activity to the AKT–STAT1–PRDX1–NF-κB pathway and provides a framework for inflammation research.
-
Protoporphyrin IX in Photodynamic Assays
2026-09-29
Protoporphyrin IX connects heme-pathway studies with photodynamic cancer diagnosis and controlled ferroptosis research, but its light sensitivity and poor solubility demand disciplined assay design. This guide provides a practical workflow, starting parameters, controls, and troubleshooting strategies for translating the compound into reproducible cell and mechanistic experiments.
-
Spermine Workflows for Ion Channel Research
2026-09-28
Spermine provides a practical perturbation tool for connecting endogenous polyamine biology with inward rectifier potassium channel assays, cellular metabolism research, and carefully bounded nuclear-envelope studies. This guide emphasizes concentration-controlled workflows, orthogonal readouts, and safeguards against mistaking a channel effect for a direct membrane-fusion mechanism.
-
Cediranib (AZD2171): Better Viability Assay Decisions
2026-09-28
Learn how to use Cediranib (AZD2171), SKU A1882, to investigate VEGFR signaling while distinguishing growth inhibition from cell death. This scenario-driven guide covers model selection, assay interpretation, compound handling, and evidence-aware product evaluation.
-
γH2AX DNA Damage Detection Kit for FLASH-RT
2026-09-27
Map radiation- or nanoparticle-associated DNA damage in individual cells with red γ-H2AX foci and blue DAPI nuclear counterstaining. This practical guide connects the γH2AX DNA Damage Detection Kit to FLASH-RT experiments while distinguishing DNA damage signaling from direct proof of cell death or repair.
-
BIBR 1532: Telomerase Inhibition Workflows
2026-09-26
Use BIBR 1532 to connect telomerase inhibition with cancer-cell growth and apoptosis readouts—while distinguishing rapid enzyme effects from the slower consequences of telomere attrition. This practical guide covers dosing, assay selection, controls, and how to interpret emerging CF10–EdU telomere findings without conflating distinct mechanisms.
-
Tomivosertib Suppresses Ectopic Activity in Human DRG
2026-09-25
A study of cultured human dorsal root ganglion neurons found that the MNK inhibitor tomivosertib rapidly and reversibly suppressed spontaneous activity in neurons associated with painful dermatomes. The findings provide direct human-neuron evidence supporting further investigation of MNK signaling in neuropathic pain, while leaving clinical efficacy and the precise ion-channel mechanisms to be established.
-
Cholesterol and the LNP Compartment Problem
2026-09-25
Cholesterol influences both membrane biology and lipid nanoparticle design, but those roles are not interchangeable. This article traces the compartments involved in intravesical p21 mRNA delivery and clarifies what the bladder cancer study does—and does not—show about cholesterol.
-
Phagocytic Giant Cancer Macrophages in Blood
2026-09-24
A two-year, multi-institutional prospective study examined circulating cancer-associated macrophage-like cells (CAMLs), described as phagocytic polyploid giant cancer cells, across six solid tumor types. The findings associate CAMLs with disease progression and spread and identify unusual proliferative and lineage-associated traits, supporting further evaluation as a blood-based research marker rather than establishing a standalone clinical test.
-
pH-Responsive cRGD-PEG-siRNA for Glioblastoma
2026-09-24
Su et al. developed a pH-responsive cRGD-PEG-siEGFR conjugate intended to improve tumor targeting and circulation while reducing renal accumulation compared with an earlier cRGD-siRNA construct. The study reports uptake and EGFR silencing in αvβ3-positive U87MG cells, alongside antitumor activity and favorable biodistribution findings; it supports further investigation of targeted siRNA delivery, not a clinical efficacy claim.
-
Dantrolene Sodium Salt in Calcium Signaling Research
2026-09-23
Use Dantrolene sodium salt to test whether ryanodine receptor–dependent calcium release contributes to disease-relevant cellular phenotypes, with practical guidance for dosing, controls, and troubleshooting. The article also puts recent CRISPR repair-pathway screening in context—an assay-design opportunity, not evidence that dantrolene itself changes DNA repair.
-
Verapamil, Txnip, and Osteoporosis: Study Analysis
2026-09-23
The reference study identifies TXNIP as a genetic and mechanistic link between verapamil exposure and osteoporosis biology. Using human genotype data, osteoclast and osteoblast assays, and an ovariectomy mouse model, the authors show that verapamil suppresses Txnip-associated bone turnover through ChREBP, PPARγ–MAPK/NF-κB, and ChREBP–Bmp2 signaling.
-
DNA Cleanup as Translational Risk Control
2026-09-22
Reliable translational biology begins with controlling preanalytical variables. This thought-leadership article explains how cation-dependent DNase I activity can be strategically deployed for RNA workflows, chromatin studies, and human-cell research, while using evidence from a human DRG study to show why sample integrity and orthogonal validation matter.